
Development of Quantitative In Vivo Imaging of Oral Biofilm pH to Allow Prevention of Enamel DemineralizationAward last edited on: 3/3/2025
Sponsored Program
SBIRAwarding Agency
NIH : NIDCRTotal Award Amount
$309,428Award Phase
1Solicitation Topic Code
121Principal Investigator
Gerald McMorrowCompany Information
Veravanti Inc
2260 152nd Avenue Ne Suite 200
Redmond, WA 98052
Redmond, WA 98052
(425) 201-6070 |
info@veravanti.com |
www.veravanti.com |
Location: Single
Congr. District: 01
County: King
Congr. District: 01
County: King
Phase I
Contract Number: 2024Start Date: ---- Completed: 6/1/2024
Phase I year
2024Phase I Amount
$309,428Public Health Relevance Statement:
NARRATIVE Tooth decay (or dental caries) is a health condition which affects 3.5 billion people annually and which primarily arises from bacterial infection from the biofilms that cover the teeth. VerAvanti intends to develop a clinically safe Optical pH device which introduces an acid-measurement technique that relies on pH-sensitive fluorescence dye as a means to detect, and even predict, locations of future demineralization and caries. This will allow dentists to determine where there is the highest risk of tooth decay, providing feedback to both the dentist and the patient as to the level of enamel health, and guide the dentist in therapeutic actions to prevent future cavities. Terms:
Phase II
Contract Number: 1R43DE032985-01A1Start Date: 5/31/2025 Completed: 00/00/00